International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.08 and traded as high as $0.12. International Stem Cell shares last traded at $0.09, with a volume of 4,007 shares traded.
International Stem Cell Stock Performance
The firm has a 50-day moving average of $0.09 and a 200-day moving average of $0.08. The firm has a market capitalization of $727,800.00, a P/E ratio of -1.14 and a beta of 0.21.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Read More
- Five stocks we like better than International Stem Cell
- How to Calculate Inflation Rate
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Comparing and Trading High PE Ratio Stocks
- Nebius Group: The Rising Star in AI Infrastructure
- Consumer Staples Stocks, Explained
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
